Sandler Laura Lee

Chief Operating Officer

Sandler Laura Lee has filed 9 SEC Form 4 filings (25 transaction rows) across 1 company, with disclosures dating back to 2026. 9 of those filings fall inside the rolling window. Most recent filing: Sep 15, 2026.

On the most recent filing, Sandler Laura Lee is listed as Chief Operating Officer at Oruka Therapeutics, Inc. Inside the rolling window, Sandler Laura Lee reported no open-market purchases and 8 open-market sales totaling $1.9M in ORKA. The largest disclosed transaction in the window is a sale of 5,000 ORKA shares on Jul 1, 2026, worth $472K.

Companies traded

Other insiders at ORKA

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.9M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ORKASale$87KSep 15SEC ↗
ORKASale$459KSep 1SEC ↗
ORKASale$472KJul 1SEC ↗
ORKASale$42KJun 15SEC ↗
ORKASale$319KMay 1SEC ↗
ORKASale$25KMar 17SEC ↗
ORKASale$168KMar 2SEC ↗
ORKASale$371KJan 2SEC ↗
Showing 1–8 of 8
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Sandler Laura Lee made?

Sandler Laura Lee has filed 9 SEC Form 4 filings (25 transaction rows) across 1 company since 2026.

Which companies does Sandler Laura Lee trade?

Sandler Laura Lee has filed SEC Form 4 disclosures for 1 company, including ORKA.

When was Sandler Laura Lee's most recent SEC Form 4 filing?

Sandler Laura Lee's most recent SEC Form 4 filing on Tracefour is dated Sep 15, 2026.

What is Sandler Laura Lee's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Sandler Laura Lee is listed as Chief Operating Officer.

What is Sandler Laura Lee's total buy and sell value in the current window?

Inside the rolling retention window, Sandler Laura Lee bought $0 and sold $1.9M based on SEC Form 4 filings.

What was Sandler Laura Lee's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 5,000 ORKA shares on 2026-07-01, worth $472K, per SEC Form 4 filings.